Should Boards Invest In The Private Enterprises Of Fellow Directors?
Elon Musk’s recent bid for the Tesla board to invest in his new AI startup leads to questions about where boards should draw the line.
Menu
Elon Musk’s recent bid for the Tesla board to invest in his new AI startup leads to questions about where boards should draw the line.
A letter the shareholders sent to the board suggests several factors that might have influenced these directors to step down.
The possibility of a CEO using or abusing illegal substances or prescription drugs presents several questions for the boardroom.
C-Suites will soon be responsible for integrating modern sustainability strategies within their organizations’ financial reporting—and boards will be responsible for oversight—but many don’t know where to start or how to track emissions.
Unless the answer is a definitive “no,” the time is now to lay the groundwork for the reporting requirements.
Whereas regular evaluations of market risks and opportunities are likely baked into board meetings, an examination of the broader regulatory landscape in which a company operates can easily be overlooked. Here’s how to get ahead of a coming storm.
Chief Executive Group exists to improve the performance of U.S. CEOs, senior executives and public-company directors, helping you grow your companies, build your communities and strengthen society. Learn more at chiefexecutivegroup.com.